IP Library Granted Patent US 9,340,827
Granted Patent B2
US 9,340,827 · App. 14/278,720 · Granted May 17, 2016

DNA polymerases with increased 3′-mismatch discrimination

Inventors: Fred Reichert (San Leandro, CA); Keith Bauer (San Rafael, CA); Thomas W. Myers (Dublin, CA)
Assignee: Roche Molecular Systems, Inc.
C12Q1/6806C12N9/1252
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,340,827
App. No.
14/278,720
Granted
May 17, 2016
Kind
B2
Abstract

Disclosed are mutant DNA polymerases having increased 3′-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.

Claims (25)

1. A recombinant nucleic acid encoding a DNA polymerase having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6 or SEQ ID NO:7, wherein the DNA polymerase comprises a motif in the polymerase domain comprising G-Y-V-E-T-L-F-G-R-R-X 5 -Y-V-P, and wherein X 5 is any amino acid other than R (SEQ ID NO:10).

2. The recombinant nucleic acid of claim 1 , wherein X 5 is an amino acid selected from the group consisting of G, A, L, M, W, P, S, T, F, Y, C, N, Q, D, E, K, V, I and H.

3. The recombinant nucleic acid of claim 1 , wherein X 5 is an amino acid selected from the group consisting of A, C, D, G, and N.

4. The recombinant nucleic acid of claim 3 , wherein X 5 is A.

5. The recombinant nucleic acid of claim 3 , wherein X 5 is C.

6. The recombinant nucleic acid of claim 3 , wherein X 5 is D.

7. The recombinant nucleic acid of claim 3 , wherein X 5 is G.

8. The recombinant nucleic acid of claim 3 , wherein X 5 is N.

9. The recombinant nucleic acid of claim 1 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is any other amino acid other than D or E.

10. The recombinant nucleic acid of claim 1 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is selected from the group consisting of L, G, T, Q, A, S, N, R, and K.

11. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is G.

12. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is L.

13. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is T.

14. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is Q.

15. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is A.

16. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is S.

17. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is N.

18. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is R.

19. The recombinant nucleic acid of claim 10 , wherein the amino acid of the DNA polymerase corresponding to position 580 of SEQ ID NO:1 is K.

20. The recombinant nucleic acid of claim 1 , wherein the DNA polymerase has at least 90% sequence identity to SEQ ID NO:1.

21. The recombinant nucleic acid of claim 1 , wherein the DNA polymerase has at least 95% sequence identity to SEQ ID NO:1.

22. The recombinant nucleic acid of claim 1 , wherein the DNA polymerase has increased 3′-mismatch discrimination activity compared with a control DNA polymerase, wherein the control DNA polymerase has the same amino acid sequence as the DNA polymerase except that the amino acid of the control DNA polymerase corresponding to position 730 of SEQ ID NO:1 is R.

23. An expression vector comprising the recombinant nucleic acid of claim 1 .

24. A host cell transformed with the expression vector of claim 23 .

25. A method for producing a DNA polymerase having increased 3 ′-mismatch discrimination activity compared with a control DNA polymerase, the method comprising culturing the host cell of claim 24 under conditions suitable for expression of the recombinant nucleic acid.

Continuity (3)
Division 13162694 · Jun 17, 2011
Provisional Application 61356219 · Jun 18, 2010
Related Publication 20140302507A1 · Oct 9, 2014